Efficacy of Individualized Homoeopathy in the Treatment of Moderate to Severe Allergic Rhinitis in Comparison with Allopathy: A Multicentric, Randomized Controlled Trial - Nil

Central Council for Research in Homoeopathy0 个研究点目标入组 0 人开始时间: 待定最近更新: 2024年3月4日

试验速览

暂无简介。

•Patients with a history of an allergic cause and one or more of the following symptoms: episodic rhinorrhoea, sneezing, obstruction of the nasal passages with lachrymation, post-nasal discharge, and pruritus of the nasal mucosa, conjunctiva and oropharynx together with the anterior rhinoscopic findings of pinkish grey pale, boggy mucosa covered with a thin glistening mucous and hypertrophied turbinates.
•Presence of moderate to severe symptoms as per ARIA classification and TNSS.
•Voluntary written informed consent.

•Patients who are not adequately symptomatic (Mild cases as per ARIA classification and TNSS) or have rhinoscopic findings not consistent with the diagnosis of AR
•Patients with serious illnesses (known cases of severe renal or hepatic diseases, malignancy, etc.)
•Patients under any medication for the symptoms of Allergic rhinitis in the past 15 days
•Cases with other causes of chronic rhinitis or complications of AR like nasal polyposis, bacterial sinusitis, etc.,
•Patients with significant psychological diseases
•Pregnancy and lactation
•Patients not ready to give informed consent.

发起方

Central Council for Research in Homoeopathy